Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;7(1):75-90.
doi: 10.1007/s13300-016-0154-2. Epub 2016 Feb 22.

The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries

Meryl Brod  1 , Annie Nikolajsen  2 , James Weatherall  3 , Kathryn M Pfeiffer  4
Affiliations

The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries

Meryl Brod et al. Diabetes Ther. 2016 Mar.

Abstract

Introduction: Post-prandial hyperglycemia (PPH) among people with diabetes is a well-known clinical challenge to diabetes management. While the economic burden of diabetes is well studied, little is known about economic costs specific to PPH. The purpose of this study was to investigate costs of PPH related to work, diabetes management, and use of healthcare resources among people with diabetes taking bolus insulin.

Methods: Data were collected in a web survey of 906 adults with type 1 (39%) and type 2 (61%) diabetes taking bolus insulin in Germany (34%), the UK (26%), and the USA (40%).

Results: Sixty-two percent of respondents experienced PPH in the past week, and respondents averaged 1.7 episodes per week. Working respondents indicated that PPH affected their work productivity: 27% missed work time and 71% experienced work productivity issues while at work due to a recent episode of PPH. In terms of diabetes management, respondents with PPH in the past week measured their blood glucose (BG) more frequently than those without PPH (3.7 vs. 2.5 times/day, P < 0.001). PPH was also significantly associated with greater use of healthcare resources. Compared to those without PPH, respondents with PPH reported greater contact with healthcare professionals related to diabetes in the past year (5.5 vs. 4.4 visits, P < 0.001; 2.7 vs. 1.4 calls/emails, P < 0.001) and were more likely to report medical complications related to diabetes (72% vs. 55%, P < 0.001). Average annual costs associated with PPH due to missed work time, additional BG test strips, and physician visits were estimated to be $1239 USD per employed person in the USA.

Conclusion: Results indicate that PPH is associated with greater economic costs and that reducing the incidence of PPH would help mitigate such costs. Additional research is needed to better understand costs associated with PPH that may be more difficult to measure, as well as more long-term impacts and costs.

Funding: Novo Nordisk.

Keywords: Diabetes management; Diabetes mellitus; Economic costs; Healthcare resources; Post-prandial hyperglycemia; Work productivity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Blood glucose measurement by experienced PPH in past week (n = 906). Note: t tests indicate significant differences by experience of PPH in past week (***P < 0.001). PPH post-prandial hyperglycemia
Fig. 2
Fig. 2
Healthcare contact related to diabetes by experienced PPH in the past week among people with a type 1 diabetes (n = 356) and b type 2 diabetes (n = 550). Note: Chi-square tests indicate significant differences by experience of PPH (***P < 0.001). PPH post-prandial hyperglycemia
See this image and copyright information in PMC

References

    1. American Diabetes Association Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–S80. doi: 10.2337/dc14-S014. - DOI - PubMed
    1. International Diabetes Federation. Guideline for management of postmeal glucose in diabetes [Internet]. 2011 [cited Mar 27, 2014]. Available from: http://www.idf.org/2011-guideline-management-postmeal-glucose-diabetes.
    1. Nathan DM, DCCT/EDIC Research Group The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16. doi: 10.2337/dc13-2112. - DOI - PMC - PubMed
    1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. doi: 10.1136/bmj.321.7258.405. - DOI - PMC - PubMed
    1. Ceriello A. The glucose triad and its role in comprehensive glycaemic control: current status, future management. Int J Clin Pract. 2010;64(12):1705–1711. doi: 10.1111/j.1742-1241.2010.02517.x. - DOI - PMC - PubMed

LinkOut - more resources